BioSpace News Archive

GeoMx Breast Cancer Consortium (GBCC) Provides Early Spatial Insights into Tumors, the Tumor Microenvironment, and the Host Immune Response

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced the appointment of Yan Zhang to the role of CEO.

Novel molecules were found to reduce inflammation and restore balance of the immune system and were also effective against pathogenic bacteria

Featuring leading neurologist Marwan Sabbagh, M.D Webinar to be held Thursday, April 15, at 1:30 p.m. PT / 4:30 p.m. ET

Anavex Life Sciences Corp. announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 at 8:45 a.m. EDT.

Bolt Biotherapeutics announced that Randall C. Schatzman, Ph.D., Chief Executive Officer, will present a company overview at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 at 10:15 AM ET.

Phase 3 Data from KEYNOTE-564 to be Presented at Upcoming Medical Meeting and Submitted to Regulatory Authorities

CareDx, Inc. announced that they have launched a fully-functional next generation sequencing HLA typing service lab in Stockholm, Sweden to support companies in research and academic studies working on HLA applications in vaccine and drug development as well as disease association studies.

Biogen enters into a commercialization and license agreement to develop, manufacture and commercialize BAT1806, a proposed biosimilar referencing ACTEMRA ® (tocilizumab) Biosimilars have the potential to enable greater access to marketed biologic therapies while generating cost savings and healthcare sustainability

Ionis Pharmaceuticals announces pivotal patient trial of antisense therapy following aggressive joint research effort led by the non-profits The ALS Association and Project ALS.